Function of cGMP-dependent protein kinases in the nervous system

Reviews in the Neurosciences

Volumn 16, Issue 1, 2005, Pages 23-41

  Feil, Robert ^a   Hofmann, Franz ^a   Kleppisch, Thomas ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Axon guidance; Cerebellum; cGMP dependent protein kinase; Circadian rhythm; Hippocampus; Learning; Nociception; Synaptic plasticity

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL MODEL; CEREBELLUM; CIRCADIAN RHYTHM; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; HIPPOCAMPUS; KNOCKOUT MOUSE; LEARNING; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS;

EID: 15944381871     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2005.16.1.23     Document Type: Review

References (115)

1. Agarwal N, Offermanns S, Kuner R. Conditional gene deletion in primary nociceptive neurons of trigeminal ganglia and dorsal root ganglia. Genesis 2004; 38: 122-129.
2. Ajima A, Ito M. A unique role of protein phosphatases in cerebellar long-term depression. NeuroReport 1995; 6: 297-300.
3. Albrecht U. The mammalian circadian clock: a network of gene expression. Front Biosci 2004; 9: 48-55.
4. Albrecht U, Eichele G. The mammalian circadian clock. Curr Opin Genet Dev 2003; 13: 271-277.
5. Arancio O, Antonova I, Gambaryan S, Lohmann SM, Wood JS, Lawrence DS, Hawkins RD. Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation. J Neurosci 2001; 21: 143-149.
6. Arancio O, Kandel ER, Hawkins RD. Activity-dependent long-term enhancement of transmitter release by presynaptic 3′,5′-cyclic GMP in cultured hippocampal neurons. Nature 1995; 376: 74-80.
7. Aswad DW, Greengard P. A specific substrate from rabbit cerebellum for guanosine 3′:5′-monophosphate-dependent protein kinase. I. Purification and characterization. J Biol Chem 1981; 256: 3487-3493.
8. Ayoob JC, Yu HH, Terman JR, Kolodkin AL. The Drosophila receptor guanylyl cyclase Gyc76C is required for semaphorin-1a-plexin A-mediated axonal repulsion. J Neurosci 2004; 24: 6639-6649.
9. Barco A, Alarcon JM, Kandel ER. Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 2002; 108: 689-703.
10. Ben-Shahar Y, Robichon A, Sokolowski MB, Robinson GE. Influence of gene action across different time scales on behavior. Science 2002; 296: 741-744.
11. Bina KG, Rusak B. Muscarinic receptors mediate carbachol-induced phase shifts of circadian activity rhythms in Syrian hamsters. Brain Res 1996; 743: 202-211.
12. Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973; 232: 331-356.
13. Bolshakov VY, Siegelbaum SA. Regulation of hippocampal transmitter release during development and long-term potentiation. Science 1995; 269: 1730-1734.
14. Boulton CL, Southam E, Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 1995; 69: 699-703.
15. Boxall AR, Garthwaite J. Long-term depression in rat cerebellum requires both NO synthase and NO-sensitive guanylyl cyclase. Eur J Neurosci 1996; 8: 2209-2212.
16. Burkhardt M, Glazova M, Gambaryan S, Vollkommer T, Butt E, Bader B, Heermeier K, Lincoln TM, Walter U, Palmetshofer A. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem 2000; 275: 33536-33541.
17. Carey M, Lisberger S. Embarrassed, but not depressed: eye opening lessons for cerebellar learning. Neuron 2002; 35: 223-226.
18. Chung HJ, Steinberg JP, Huganir RL, Linden DJ. Requirement of AMPA receptor GluR2 phosphorylation for cerebellar long-term depression. Science 2003; 300: 1751-1755.
19. Davis S, Salin H, Helme-Guizon A, Dumas S, Stephan A, Corbex M, Mallet J, Laroche S. Dysfunctional regulation of alphaCaMKII and syntaxin 1B transcription after induction of LTP in the aged rat. Eur J Neurosci 2000; 12: 3276-3282.
20. de Vente J, Asan E, Gambaryan S, Markerink-van Ittersum M, Axer H, Gallatz K, Lohmann SM, Palkovits M. Localization of cGMP-dependent protein kinase type II in rat brain. Neuroscience 2001; 108: 27-49.
21. De Zeeuw CI, Hansel C, Bian F, Koekkoek SK, van Alphen AM, Linden DJ, Oberdick J. Expression of a protein kinase C inhibitor in Purkinje cells blocks cerebellar LTD and adaptation of the vestibulo-ocular reflex. Neuron 1998; 20: 495-508.
22. Dere E, Frisch C, De Souza Silva MA, Godecke A, Schrader J, Huston JP. Unaltered radial maze performance and brain acetylcholine of the endothelial nitric oxide synthase knockout mouse. Neuroscience 2001; 107: 561-570.
23. Dickson BJ. Molecular mechanisms of axon guidance. Science 2002; 298: 1959-1964.
24. Ding JM, Chen D, Weber ET, Faiman LE, Rea MA, Gillette MU. Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science 1994; 266: 1713-1717.
25. Ding JM, Faiman LE, Hurst WJ, Kuriashkina LR, Gillette MU. Resetting the biological clock: mediation of nocturnal CREB phosphorylation via light, glutamate, and nitric oxide. J Neurosci 1997; 17: 667-675.
26. Dontchev VD, Letourneau PC. Nerve growth factor and semaphorin 3A signaling pathways interact in regulating sensory neuronal growth cone motility. J Neurosci 2002; 22: 6659-6669.
27. el-Husseini AE, Bladen C, Vincent SR. Molecular characterization of a type II cyclic GMP-dependent protein kinase expressed in the rat brain. J Neurochem 1995; 64: 2814-2817.
28. El-Husseini AE, Williams J, Reiner PB, Pelech S, Vincent SR. Localization of the cGMP-dependent protein kinases in relation to nitric oxide synthase in the brain. J Chem Neuroanat 1999; 17: 45-55.
29. Eskin A, Takahashi JS, Zatz M, Block GD. Cyclic guanosine 3′:5′-monophosphate mimics the effects of light on a circadian pacemaker in the eye of Aplysia. J Neurosci 1984; 4: 2466-2471.
30. Feil R, Hartmann J, Luo C, Wolfsgruber W, Schilling K, Feil S, Barski JJ, Meyer M, Konnerth A, De Zeeuw CI, Hofmann F. Impairment of LTD and cerebellar learning by Purkinje cell-specific ablation of cGMP-dependent protein kinase I. J Cell Biol 2003; 163: 295-302.
31. Feil R, Lohmann SM, de Jonge H, Walter U, Hofmann F. Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ Res 2003; 93: 907-916.
32. Frey UA, Krug M, Reymann KG, Matthies H. Anisomycin, an inhibitor of protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro. Brain Res 1988; 452: 57-65.
33. Frisch C, Dere E, Silva MA, Godecke A, Schrader J, Huston JP. Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum. J Neurosci 2000; 20: 6694-6700.
34. Fujiwara M, Sengupta P, McIntire SL. Regulation of body size and behavioral state of C. elegans by sensory perception and the EGL-4 cGMP-dependent protein kinase. Neuron 2002; 36: 1091-1102.
35. Gambaryan S, Geiger J, Schwarz UR, Butt E, Begonja A, Obergfell A, Walter U. Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase. Blood 2004; 103: 2593-2600.
36. Geiselhoringer A, Gaisa M, Hofmann F, Schlossmann J. Distribution of IRAG and cGKI-isoforms in murine tissues. FEBS Lett 2004; 575: 19-22.
37. Gillette MU. Cellular and biochemical mechanisms underlying circadian rhythms in vertebrates. Curr Opin Neurobiol 1997; 7: 797-804.
38. Gillette MU, Mitchell JW. Signaling in the suprachiasmatic nucleus: selectively responsive and integrative. Cell Tissue Res 2002; 309: 99-107.
39. Hall KU, Collins SP, Gamm DM, Massa E, DePaoli-Roach AA, Uhler MD. Phosphorylation-dependent inhibition of protein phosphatase-1 by G-substrate. A Purkinje cell substrate of the cyclic GMP-dependent protein kinase. J Biol Chem 1999; 274: 3485-3495.
40. Harkin AJ, Bruce KH, Craft B, Paul IA. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur J Pharmacol 1999; 372: 207-213.
41. Hartell NA. cGMP acts within cerebellar Purkinje cells to produce long term depression via mechanisms involving PKC and PKG. NeuroReport 1994; 5: 833-836.
42. Hebb DO. The Organisation of Behavior. A Neurophsychological Theory. New York: Wiley, 1949.
43. Heiberg I, Wegener G, Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav Brain Res 2002; 134: 479.
44. Hofmann F, Ammendola A, Schlossmann J. Rising behind NO: cGMP-dependent protein kinases. J Cell Sci 2000; 113: 1671-1676.
45. Hofmann F, Biel M, Feil R, Kleppisch T. Mouse models of NO/natriuretic peptide/cGMP kinase signaling. In: Hein L, Offermanns S, eds. Handbook of Experimental Pharmacology. Amsterdam: Elsevier, 2004; 95-130.
46. Hofmann F, Sold G. A protein kinase activity from rat cerebellum stimulated by guanosine-3′:5′-monophosphate. Biochem Biophys Res Commun 1972; 49: 1100-1107.
47. Ito I, Sakimura K, Mishina M, Sugiyama H. Age-dependent reduction of hippocampal LTP in mice lacking N-methyl-D-aspartate receptor epsilon 1 subunit. Neurosci Lett 1996; 203: 69-71.
48. Ito M. Cerebellar long-term depression: characterization, signal transduction, and functional roles. Physiol Rev 2001; 81: 1143-1195.
49. Ito M. The molecular organization of cerebellar long-term depression. Nat Rev Neurosci 2002; 3: 896-902.
50. Jarchau T, Hausler C, Markert T, Pohler D, Vanderkerckhove J, De Jonge HR, Lohmann SM, Walter U. Cloning, expression, and in situ localization of rat intestinal cGMP-dependent protein kinase II. Proc Natl Acad Sci USA 1994; 91: 9426-9430.
51. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001; 413: 203-210.
52. Katoh A, Kitazawa H, Itohara S, Nagao S. Inhibition of nitric oxide synthesis and gene knockout of neuronal nitric oxide synthase impaired adaptation of mouse optokinetic response eye movements. Learn Mem 2000; 7: 220-226.
53. Keilbach A, Ruth P, Hofmann F. Detection of cGMP dependent protein kinase isozymes by specific antibodies. Eur J Biochem 1992; 208: 467-473.
54. Kirkwood A, Silva A, Bear MF. Age-dependent decrease of synaptic plasticity in the neocortex of alpha CaMKII mutant mice. Proc Natl Acad Sci USA 1997; 94: 3380-3383.
55. Kleppisch T, Pfeifer A, Klatt P, Ruth P, Montkowski A, Fassler R, Hofmann F. Long-term potentiation in the hippocampal CA1 region of mice lacking cGMP-dependent kinases is normal and susceptible to inhibition of nitric oxide synthase. J Neurosci 1999; 19: 48-55.
56. Kleppisch T, Wolfsgruber W, Feil S, Allmann R, Wotjak CT, Goebbels S, Nave KA, Hofmann F, Feil R. Hippocampal cGMP-dependent protein kinase I supports an age- and protein synthesis-dependent component of long-term potentiation but is not essential for spatial reference and contextual memory. J Neurosci 2003; 23: 6005-6012.
57. Lanahan A, Lyford G, Stevenson GS, Worley PF, Barnes CA. Selective alteration of long-term potentiation-induced transcriptional response in hippocampus of aged, memory-impaired rats. J Neurosci 1997; 17: 2876-2885.
58. Lebrand C, Dent EW, Strasser GA, Lanier LM, Krause M, Svitkina TM, Borisy GG, Gertler FB. Critical role of Ena/VASP proteins for filopodia formation in neurons and in function downstream of netrin-1. Neuron 2004; 42: 37-49.
59. L'Etoile ND, Coburn CM, Eastham J, Kistler A, Gallegos G, Bargmann CI. The cyclic GMP-dependent protein kinase EGL-4 regulates olfactory adaptation in C. elegans. Neuron 2002; 36: 1079-1089.
60. 2+ in the induction of cerebellar long-term depression. Neuron 1997; 18: 1025-1038.
61. 2+ transients. Neuron 1995; 15: 407-415.
62. Lev-Ram V, Nebyelul Z, Ellisman MH, Huang PL, Tsien RY. Absence of cerebellar long-term depression in mice lacking neuronal nitric oxide synthase. Learn Mem 1997; 4: 169-177.
63. Lewin MR, Walters ET. Cyclic GMP pathway is critical for inducing long-term sensitization of nociceptive sensory neurons. Nat Neurosci 1999; 2: 18-23.
64. Liu C, Ding JM, Faiman LE, Gillette MU. Coupling of muscarinic cholinergic receptors and cGMP in nocturnal regulation of the suprachiasmatic circadian clock. J Neurosci 1997; 17: 659-666.
65. Liu C, Gillette MU. Cholinergic regulation of the suprachiasmatic nucleus circadian rhythm via a muscarinic mechanism at night. J Neurosci 1996; 16: 744-751.
66. Lohmann SM, Vaandrager AB, Smolenski A, Walter U, De Jonge HR. Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci 1997; 22: 307-312.
67. Lohmann SM, Walter U, Miller PE, Greengard P, De Camilli P. Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain. Proc Natl Acad Sci USA 1981; 78: 653-657.
68. Lu YF, Hawkins RD. Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus. J Neurophysiol 2002; 88: 1270-1278.
69. Lu YF, Kandel ER, Hawkins RD. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J Neurosci 1999; 19: 10250-10261.
70. Mathur A, Golombek DA, Ralph MR. cGMP-dependent protein kinase inhibitors block light-induced phase advances of circadian rhythms in vivo. Am J Physiol 1996; 270: R1031-1036.
71. Mauk MD, Garcia KS, Medina JF, Steele PM. Does cerebellar LTD mediate motor learning? Toward a resolution without a smoking gun. Neuron 1998; 20: 359-362.
72. Metzger D, Feil R. Engineering the mouse genome by site-specific recombination. Curr Opin Biotechnol 1999; 10: 470-476.
73. Milner B. Visual recognition and recall after right temporal-lobe excision in man. Epilepsy Behav 2003; 4: 799-812.
74. Moore RY, Eichler VB. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res 1972; 42: 201-206.
75. Moore RY, Lenn NJ. A retinohypothalamic projection in the rat. J Comp Neurol 1972; 146: 1-14.
76. Muller U. The nitric oxide system in insects. Prog Neurobiol 1997; 51: 363-381.
77. Niedbala B, Sanchez A, Feria M. Nitric oxide mediates neuropathic pain behavior in peripherally denervated rats. Neurosci Lett 1995; 188: 57-60.
78. 2+ channels sets the polarity of nerve growth-cone turning. Nature 2003; 423: 990-995.
79. Orstavik S, Sandberg M, Berube D, Natarajan V, Simard J, Walter U, Gagne R, Hansson V, Jahnsen T. Localization of the human gene for the type I cyclic GMP-dependent protein kinase to chromosome 10. Cytogenet Cell Genet 1992; 59: 270-273.
80. Orstavik S, Solberg R, Tasken K, Nordahl M, Altherr MR, Hansson V, Jahnsen T, Sandberg M. Molecular cloning, cDNA structure, and chromosomal localization of the human type II cGMP-dependent protein kinase. Biochem Biophys Res Commun 1996; 220: 759-765.
81. Osborne KA, Robichon A, Burgess E, Butland S, Shaw RA, Coulthard A, Pereira HS, Greenspan RJ, Sokolowski MB. Natural behavior polymorphism due to a cGMP-dependent protein kinase of Drosophila. Science 1997; 277: 834-836.
82. Oster H, Werner C, Magnone MC, Mayser H, Feil R, Seeliger MW, Hofmann F, Albrecht U. cGMP-dependent protein kinase II modulates mPer1 and mPer2 gene induction and influences phase shifts of the circadian clock. Curr Biol 2003; 13: 725-733.
83. Pfeifer A, Aszodi A, Seidler U, Ruth P, Hofmann F, Fassler R. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science 1996; 274: 2082-2086.
84. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R, Hofmann F. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 1998; 17: 3045-3051.
85. Pfeifer A, Ruth P, Dostmann W, Sausbier M, Klatt P, Hofmann F. Structure and function of cGMP-dependent protein kinases. Rev Physiol Biochem Pharmacol 1999; 135: 105-149.
86. Polleux F, Morrow T, Ghosh A. Semaphorin 3A is a chemoattractant for cortical apical dendrites. Nature 2000; 404: 567-573.
87. Prosser RA, McArthur AJ, Gillette MU. cGMP induces phase shifts of a mammalian circadian pacemaker at night, in antiphase to cAMP effects. Proc Natl Acad Sci USA 1989; 86: 6812-6815.
88. Qian Y, Chao DS, Santillano DR, Cornwell TL, Nairn AC, Greengard P, Lincoln TM, Bredt DS. cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons. J Neurosci 1996; 16: 3130-3138.
89. Raymond JL, Lisberger SG, Mauk MD. The cerebellum: a neuronal learning machine? Science 1996; 272: 1126-1131.
90. Reisel D, Bannerman DM, Schmitt WB, Deacon RM, Flint J, Borchardt T, Seeburg PH, Rawlins JN. Spatial memory dissociations in mice lacking GluR1. Nat Neurosci 2002; 5: 868-873.
91. Revermann M, Maronde E, Ruth P, Korf HW. Protein kinase G I immunoreaction is colocalized with arginine-vasopressin immunoreaction in the rat suprachiasmatic nucleus. Neurosci Lett 2002; 334: 119-122.
92. Salmhofer H, Neuhuber WL, Ruth P, Huber A, Russwurm M, Allescher HD. Pivotal role of the interstitial cells of Cajal in the nitric oxide signaling pathway of rat small intestine. Morphological evidence. Cell Tissue Res 2001; 305: 331-340.
93. Schlossmann J, Ammendola A, Ashman K, Zong X, Huber A, Neubauer G, Wang GX, Allescher HD, Korth M, Wilm M, Hofmann F, Ruth P. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 2000; 404: 197-201.
94. Schmidt H, Werner M, Heppenstall PA, Henning M, More MI, Kuhbandner S, Lewin GR, Hofmann F, Feil R, Rathjen FG. cGMP-mediated signaling via cGKIalpha is required for the guidance and connectivity of sensory axons. J Cell Biol 2002; 159: 489-498.
95. Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. J Neurochem 1957; 20: 11-21.
96. Song H, Ming G, He Z, Lehmann M, McKerracher L, Tessier-Lavigne M, Poo M. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science 1998; 281: 1515-1518.
97. Sousa AM, Prado WA. The dual effect of a nitric oxide donor in nociception. Brain Res 2001; 897: 9-19.
98. Stephan FK, Zucker I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA 1972; 69: 1583-1586.
99. Sung YJ, Walters ET, Ambron RT. A neuronal isoform of protein kinase G couples mitogen-activated protein kinase nuclear import to axotomy-induced long-term hyperexcitability in Aplysia sensory neurons. J Neurosci 2004; 24: 7583-7595.
100. Tegeder I, Del Turco D, Schmidtko A, Sausbier M, Feil R, Hofmann F, Deller T, Ruth P, Geisslinger G. Reduced inflammatory hyperalgesia with preservation of acute thermal nociception in mice lacking cGMP-dependent protein kinase I. Proc Natl Acad Sci USA 2004; 101: 3253-3257.
101. Tegeder I, Schmidtko A, Niederberger E, Ruth P, Geisslinger G. Dual effects of spinally delivered 8-bromo-cyclic guanosine mono-phosphate (8-bromo-cGMP) in formalin-induced nociception in rats. Neurosci Lett 2002; 332: 146-150.
102. Tischkau SA, Mitchell JW, Pace LA, Barnes JW, Barnes JA, Gillette MU. Protein kinase G type II is required for night-to-day progression of the mammalian circadian clock. Neuron 2004; 43: 539-549.
103. Tischkau SA, Weber ET, Abbott SM, Mitchell JW, Gillette MU. Circadian clock-controlled regulation of cGMP-protein kinase G in the nocturnal domain. J Neurosci 2003; 23: 7543-7550.
104. Uhler MD. Cloning and expression of a novel cyclic GMP-dependent protein kinase from mouse brain. J Biol Chem 1993; 268: 13586-13591.
105. Vivancos GG, Parada CA, Ferreira SH. Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues. Br J Pharmacol 2003; 138: 1351-1357.
106. Wall ME, Francis SH, Corbin JD, Grimes K, Richie-Jannetta R, Kotera J, Macdonald BA, Gibson RR, Trewhella J. Mechanisms associated with cGMP binding and activation of cGMP-dependent protein kinase. Proc Natl Acad Sci USA 2003; 100: 2380-2385.
107. Wang KH, Brose K, Arnott D, Kidd T, Goodman CS, Henzel W, Tessier-Lavigne M. Biochemical purification of a mammalian slit protein as a positive regulator of sensory axon elongation and branching. Cell 1999; 96: 771-784.
108. Wang X, Robinson PJ. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem 1997; 68: 443-456.
109. Wang YT, Linden DJ. Expression of cerebellar long-term depression requires postsynaptic clathrin-mediated endocytosis. Neuron 2000; 25: 635-647.
110. Weber ET, Gannon RL, Rea MA. cGMP-dependent protein kinase inhibitor blocks light-induced phase advances of circadian rhythms in vivo. Neurosci Lett 1995; 197: 227-230.
111. Wegener JW, Nawrath H, Wolfsgruber W, Kuhbandner S, Werner C, Hofmann F, Feil R. cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium. Circ Res 2002; 90: 18-20.
112. Werner C, Raivich G, Cowen M, Stelakowa T, Sillaber I, Buters JT, Spanagel R, Hofmann F. Importance of NO/cGMP signaling via cGMP-dependent protein kinase II for controlling emotionality and neurobehavioural effects of alcohol. Eur J Neurosci 2004; 20: 3498-3506.
113. Wernet W, Flockerzi V, Hofmann F. The cDNA of the two isoforms of bovine cGMP-dependent protein kinase. FEBS Lett 1989; 251: 191-196.
114. Zamanillo D, Sprengel R, Hvalby O, Jensen V, Burnashev N, Rozov A, Kaiser KM, Koster HJ, Borchardt T, Worley P, Lubke J, Frotscher M, Kelly PH, Sommer B, Andersen P, Seeburg PH, Sakmann B. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 1999; 284: 1805-1811.
115. Zhuo M, Hu Y, Schultz C, Kandel ER, Hawkins RD. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 1994; 368: 635-639.